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Eight human brains with clinical signs of "hepatocerebral degeneration" (6 alcoholic and 2 post hepatitic in aetiology) were examined
in 4 different regions for their content of cerebroside, sphingomyelin, phosphatidyl choline, phosphatidyl ethanolamine, and cholesterol.
Compared with normal brains the lipid content was reduced in all these regions. The grey matter showed mainly a reduction of cerebroside,
whereas significant loss of cerebroside, phosphatidyl choline, phosphatidyl ethanolamine, and cholesterol was found in the myelin rich
areas. Apart from parenchymal oedema, morphological changes were not apparent in the brains examined. These findings suggest that in
"hepatocerebral degeneration" there is a pre-morphological, generalised cerebral degeneration involving the structural lipids which cannot
be attributed to the physiological ageing process.
Acht menschliche Gehirne mit den klinischen Zeichen der hepatocerebralen Degeneration (6 infolge alkohol-toxischer und 2 infolge
posthepatitischer Cirrhosen) wurden in 4 verschiedenen Regionen auf ihren Gehalt an Cerebrosid, Sphingomyelin, Phosphatidylcholin,
Phosphatidyläthanolamin und Cholesterin untersucht. Verglichen mit Normalgehirnen war der Lipidgehalt in den untersuchten Regionen
reduziert. Die graue Substanz zeigte insbesondere eine Verminderung an Cerebrosid, während in den myelin-reichen Regionen ein signi-
fikanter Verlust von Cerebrosid, Phosphatidylcholin, Phosphatidyläthanolamin und Cholesterin nachzuweisen war. — Von einem ödem
des Gehirnes abgesehen konnten auffallende morphologische Veränderungen nicht gefunden werden. Die Ergebnisse deuten darauf hin,
daß es sich bei der hepatocerebralen Degeneration um eine prä-morphologische, allgemeine cerebrale Degeneration unter Mitbeteiligung
der Strukturlipide handelt, welche durch den physiologischen Alterungsprozeß allein nicht erklärt werden kann.
The rising consumption of alcoholic drinks in the so
called wealthy countries has resulted in alcoholic
cirrhosis becoming an increasing social problem. The
absolute amount of alcohol which leads to cirrhosis
varies from person to person. As a general guide
100—180 grams of pure alcohol per day (1) can lead
to cirrhosis within 5—20 years, although it is known that
cirrhosis may occur within 1—2 years (2). Neurological
and mental changes described as hepatocerebral degene-
ration are a frequent result of this liver disease.
"Hepatocerebral degeneration" is a syndrome in which
liver and brain are simultaneously involved and show
both morphological and functional changes (3). One
widely recognised difficulty is that cerebral symptoms
do not necessarily reflect the degree of liver damage (4).
The clinical signs of hepatocerebral degeneration may
appear days before hepatic coma or sometimes not at all.
This lack of correlation is also illustrated by the WER-
NiCKE-KoRSAKOFF syndrome in which by definition
liver lesion is absent.
Liver insufficiency is accompanied by various metabolic
changes. There is a clear rise in the blood level of certain
metabolites, particularly those derived from protein
breakdown. These include ammonia, free phenols,
phenylcarbonic acids, indole and amines. One current
view of the aetiology and pathogenesis of hepato-
cerebral degeneration is that the substances mentioned
could bring about toxic damage (5) probably due to
their lipid affinity (6).
Histological and electronmicroscopical changes are found
in the brain in this type of degeneration. These have been
described as nerve cell disintegration and parenchymal
swelling (7), vacuolation of the astrocytes (8), enlarge-
ment of the astrocyte nucleus in the glpbus pallidus (9)
or the appearance of carmine positive substances in the
glial cell nuclei (10).
The metabolic abnormalities which preceed morpho-
logical damage are unknown and controversial (11). The
problem of the metabolic and histochemical changes
involved in hepatocerebral degeneration is not dealt
with in one of the above accounts (3). As we have pre-
viously investigated the lipid and fatty acid composition
of normal human brain we decided to make correspond-
ing studies in hepatocerebral degeneration.
Materials and Methods
Normal brains
Six brains of patients aged 50 to 80 years who had died of non-
cerebral disease and were free of morbid anatomical changes were
examined. The data have been partly published (12, 13) but we_
carried out supplementary examinations for the purpose of this
study.
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Degenerated brains
Eight brains of patients who had died as a result of ckrhosis were
examined. Six of these were from patients who had alcoholic
cirrhosis, two from patients who had post hepatitic cirrhosis. The
patients in the alcoholic group had a history of excessive alcohol
consumption lasting for years (e. g. patient I and II total intake
estimated at between 700 and 1500 1 of pure ethanol in 2 years).
All patients excepting number V had been on stationary treatment
(tab. 1) several times for repeated bleeding from oesophageal
varices or pronounced neurological or mental symptoms.
Anamnesis
The difficulties in obtaining exact data about the duration of a
patient's alcohol history from himself or from his family are well
known. In our patients statements fluctuated in the range 5 to 10
years with repeated inquiry. We are unable to give clear data about
the history of the non alcoholic cirrhosis, but in both cases the
acute hepatitis dates back to between 25 and 30 years before death.
Thus with respect to the duration and severity of alcohol con-
sumption and of the age of the non alcohol-related liver cirrhosis
respectively we are dependent upon estimations.
CIinica( examinations
During the patients' clinical treatment, the following neurological
and mental symptoms were noticed: flapping tremor 6, dysphagia 2,
apraxia 2, rigidity 3, drowsiness and periodic stupor 3, indifference
1, and changes in the sleep rhythm 1. Patient Π had a coincident
generalised psoriasis vulgaris. The serum content of ammonia,
free phenols, >-hydroxyphenyl acetic acid (tab. 1) were determined
in all 6 patients. These serum levels were not proportional to the
severity of the clinical symptoms.
Brain regions
20 grams of tissue were taken from the following regions of the
brains within 48 h of death:
grey matter (cortex) of cerebrum (frontal, parietal, occipital)
white matter of cerebrum
cerebellum (grey and white matter mixed)
medulk oblongata (and parts of pons).
Lipid extraction and separation
The detailed description of the lipid extraction appeared in previous
publications (13,14). The samples of the single brain regions were
deep frozen and kept at — 15° to — 25° C until used. The isolation
of the total lipid extract was done in identical ways with the same
DEAE and silica gel columns and with the same organic solvents
etc.
Using the method of FOLCH (15), 10 g fresh or frozen tissue of each
region with 20 times the volume chloroform-methanol 2:1, was
homogenized, washed with a salt solution (chloroform-methanol-
water 3:48:47 v/v/v + 2.9 g NaCl + 267 mg CaCl2 + 363 mg
MgCl2/l), dried, heat coagulated after being redisolved in small
amounts of chloroform-methanol 2:1, filtered with extracted filter
papers and dried. The substances found correspond to the total
protein-free lipids (fig. 1). 400—1200 mg of total lipids were applied
to a DEAE-Sephadex column. We eluted the non-acidic or so
called neutral lipids (16) quantitatively with 300 ml chloroform-
methanol 2:1. The subsequent elution procedure (acidic lipids,
free fatty acids, etc., see fig. 1) is not of interest for this paper.
The neutral lipids were separated into 4 fractions with an ammonia
silica gel column: cholesterol, cerebroside (incl. ceramide), phos-
phatidyl ethanolamine (incl. plasmalogens), and a mixture con-
taining phosphatidyl choline and sphingomyelin. The last fraction
Tab. 1 Patients
Pat. sex age Diagnosis
Brain Clinical Symptoms Serum levels
Cause of death Autopsy Histology psychic neurological NH3 p-HPAA*
I cf 38 Decompensated, alcohol-
related liver cirrhosis,
Diabetes mellitus
II cf 55 Decompensated, alcohol-
related liver cirrhosis, Ascites,
Psoriasis vulgaris
ΠΙ o* 56 Atrophie, alcohol-related
liver cirrhosis
IV cf 58 Decompensated, alcohol-
related liver cirrhosis,
Ascites
V 9 58 Active, alcohol-related
liver cirrhosis,
Pyrazolon abuse
Cf 50 Highly active, alcohol-
related, liver cirrhosis
Cf 59 Active, post hepatitic liver
cirrhosis
Cf 65 Atrophie, post hepatitic
liver cirrhosis
VI
VII
VIII
Controls
Oesophageal piles Oedema (—) -f-f + f t
haemorrhage
Hepatargy Oedema (—) + + 4- ++ t
Hepatic coma
Hypokalaemia
Oesophageal piles cortic. 4- + + -f -f f
haemorrhage atrophy
Cardiac failure Oedema (4-) -f-l· +4· ?
Pulmonary oedema
Gastric haemorrhage ? ? + + ?
Hepatargy Oedema + 4-+ 4- 4-4- t f
Hepatargy, Gastric (—) — — (-f) —
haemorrhage
Hepatargy Oedema — + 4- -f —
IX
X
XI
XII
XIII
XIV
cf
cf
9
9
9
cf
73
69
69
70
62
79
Bronchopneumonia
My oca r dial infarction
Pulmonary infarction
Accident
Carcinoma of the ovary
Carcinoma of the prostate
Circulatory
insufficiency
Circulatory
insufficiency
Cardiac insufficiency
Accident
Cachexia
Cachexia
normal
normal
normal
normal
normal
normal
— — not studied
— — not studied
— — not studied
unknown unknown
— — not studied
— — not studied
* p-hydroxyphenyl acetic acid
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Elution scheme for isolation of brain lipids and determination of fatty acid methylesters
*) This cholesterol fraction includes small amounts of cholesteryl ***) This fraction contains all acidic Hpids (sulphatides, phosphatidic
esters and traces of glycerides . acids, phosphatidyl serine, phosphatidyl inositides, gangliosides,
**) Methanol elutes very small amounts of water soluble nonlipid, free fatty acids, and other minor components)
lysophosphatidyl ethanolamine and some oxidation products of ****) ethanol-free, amylene stabilized chloroformlysophosphatidyl ethanolamine and lysophosphatidyl choline
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Tab. 2
Dry weight and total lipids in % of fresh weight; neutral lipids, and lipid fractions in % of total lipids in brains of normals (n « 6) and of patients
with alcohol-related liver cirrhosis (n = 6) and with posthepatitic cirrhosis (n «· 2). Mean values and standard deviation
Grey matter
normal brains of patients
brain with
alcohol post-
related hepatitic
liver cirrhosis
Dry weight
Total lipids
Neutral lipids
Cholesterol
Cerebroside
Sphingomyelin
Phosphatidyl choline
Phosphatidyl ethanolamine
Phosphatidal ethanolamine
X
s
X
s
χ
s
χ
s
χ
s
χ
s
χ
s
5c
s
χ
s
18.6
1.27
5.6
0.64
83.8
2.50
22.1
1.06
11.8
2.55
5.3
0.65
22.1
3.24
21.3
2.74
2.0
0.44
17.1
1.47
4.1
0.72
77.7*
4.04
21.2
1.38
8.4*
1.87
6.3
2.32
20.6
3.27
19.6
4.34
1.5
0.66
19.6
5.16
5.6
0.64
81.7
0.71
23.5
0.85
8.2
1.48
6.9
0.71
19.9
1.70
21.4
0.35
1.9
0.10
White matter
normal brains of patients
brain with
alcohol post-
related hepatitic
liver cirrhosis
32.5
3.13
13.3
1.28
84.3
0.85
25.1
0.58
21.0
2.37
8.1
0.97
12.3
1.61
16.3
1.73
1.6
0.33
34.7
2.00
14.0
2.87
67.0***
4.95
21.3*
1.85
16.3***
1.19
7.1
0.69
8.8**
0.52
12.0*
2.40
1.6
0.53
34.0
0.78
12.5
3.04
76.4**
1.27
23.5
0.92
17.7
1.13
8.0
0.10
10.2
0.99
15.1
0.71
2.1
0.14
Cerebellum
normal brains of patients
brain with
alcohol post-
related hepatitic
liver cirrhosis
23.6
2.69
9.1
1.50
83.0
2.32
23.0
2.14
15.1
1.94
7.5
1.19
15.7
2.31
20.3
1.82
2.0
0.42
23.5
1.94
6.7
1.36
76.3*
4.93
21.7
1.66
13.3
1.69
7.4
1.30
15.2
1.69
16.9
2.87
1.9
0.39
24.2
2.47
7.8
0.49
83.2
1.06
24.9
1.98
13.5
1.41
8.5
0.85
14.2
1.20
19.4
2.62
2.8
0.10
Medulla oblongata
normal brains of patients
brain with
alcohol post-
related hepatitic
liver cirrhosis
32.7
2.41
15.4
2.48
85.0
2.09
25.9
0.56
22.5
1.55
8.4
0.90
11.3
1.20
16.5
1.46
1.6
0.49
32.5
2.82
13.4
2.76
70.4***
4.89
22.5*
1.63
15.7***
2.21
7.2
1.39
9.4*
1.02
13.4*
1.26
1.7
0.40
33.2
3.11
13.3
2.55
77.2***
0.49
23.9
0.85
16.1*
1.63
9.0
1.84
9.9
1.56
15.7
0.10
2.4
0.57
*) p < 0.05 **) p < 0.01 ***) p < 0.001
was then treated with alkali (0.5 mol/1 sodium methoxide in
chloroform-methano] (dry) 1:1) (17) for 15 h at room temperature.
This hydrolyzed the phosphatidyl choline and the fatty acid
methyl esters could be separated from the unchanged Sphingo-
myelin on a silica gel column. The methyl esters and lipid could
then be purified separately on further columns.
The phosphatidal ethanolamine (plasmalogen) was determined as
the fatty aldehydes by gas chromatography analysis of the fatty
acid methyl ester mixture of the phosphatidyl ethanolamine. The
amount of the fatty aldehydes was subtracted from the fatty acid
mixture to give a value for the calculation of the phosphatidal
ethanolamine. In table 2 second row, are shown the amounts of
phosphatidyl ethanolamine after the above correction of the deter-
mined phosphatidal ethanolamine.
Control of purity
After the gravimetric determination of the total pure lipid ex-
tracted, the degree of purity was examined microanalytically
(phosphate and hexose determination) and by thin layer chromato-
graphy. The cerebrosides of white matter contained nearly theo-
retical amounts of hexose (92—98%) but these of grey matter
seemed to be more contaminated (hexose 87—92% of theoretical
amount).
Results
Total and neutral lipids
The total lipids which had been extracted and separated
from the protein-containing lipids showed marked
differences between the different regions. In the alcohol-
related hepatogen degenerated brains the highest lipid
content was found in the white matter of cerebrum
(14% of the fresh weight), the lowest in the grey matter
of cerebrum (4.1%). But the lipid concentration in all
parts of die pathological brains examined was lower than
in the normal brains. However, the differences are not
significant (STUDENT'S t-test).
The neutral lipids are obtained by separation on a
DEAE-Sephadex column. In pathological brains the
neutral lipids constitute 77.7% of the total lipids in grey
matter of cerebrum and 67.0% in white matter of
cerebrum. The neutral lipids of the pathological brains
are therefore significantly diminished because the total
lipids of the healthy control brains show more than
80% neutral lipids (tab. 2) in the 4 studied regions.
This decrease can also be shown to a lesser degree in
both the brains with post hepatitic cirrhosis.
Cholesterol
In the parts of the brain abundant in myelin sheaths
(the white matter of cerebrum and medulla oblongata),
a significant decrease of cholesterol was found. This
decrease was 3—4% in relation to the total lipids or
13—15% in comparison to the cholesterol content in the
normal brains (tab. 2). In the regions of the brain with
a small content of myelin sheaths (the grey matter of
cerebrum and cerebellum), no clear difference between
normal and pathological brains was found.
Neutral Sphingolipids
Of all the lipid fractions examined the cerebroside
fraction showed the most marked decrease. In 3 regions
of pathological brains there was a decrease of 3—7% in
relation to the total lipids as opposed to the normal
brains: the content was about 8% in the grey matter of
cerebrum and 16% in the white matter of cerebrum.
However, the Sphingomyelin of the pathological brains
showed no change compared to normal brains with a
concentration of between 6.0 and 7.5%.
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Glycerophospbatides (tab. 2)
Of the glycerophosphatides, the phosphatidyl choline
and phosphatidyl ethanolamine were examined. In the
grey matter of cerebrum roughly 20% lecithin was found
and in the cerebellum 15%, with approximately 9% in
the white matter of cerebrum and medulla oblongata.
The differences in these regions are significant in the
pathological brains as well as in the normal brains. The
pure phosphatidyl ethanolamine showed roughly the
same concentration as the phosphatidyl choline in the
scanty myelin regions of the grey matter of cerebrum
and cerebellum; its content was about 40% more than
the phosphatidyl choline in the regions rich in myelin
with a level of between 12% and 13% in comparison to
the total lipids. Compared with normal brains, a signi-
ficant decrease of phosphatidyl choline and phosphatidyl
ethanolamine was found in the white matter of cerebrum
and medulla oblongata of the pathological brains.
The phosphatidal ethanolamine was equally well re-
presented in the pathological and normal brains. The.
main components of the separated fatty aldehydes were
identified as those with 16 and 18 C-atoms.
Discussion
The lipids of the human brain are essential constituents
of the cell membranes or myelin sheaths (18), and
specifically participate in the oxidative phosphorylation
of nerve cells and the conduction of action potentials in
the nerve fibres (19).
From birth until the end of the myelination phase, these
structural lipids undergo quantitative changes, but with
the exception of slight structural differences in the
sphingosine bases (20) qualitative changes could not be
demonstrated.The total lipid content increases with onto-
genetic development. At birth it amounts to 2—3% of
the fresh weight (21, 22), in adults to 5—6% in the grey
matter and to 12—16% in the white matter. The pro-
portion of particular lipids also changes with develop-
ment: phospatidyl choline and cholesterol decrease as
myelination proceeds whilst cerebroside and sphingo-
myelin increase relatively and absolutely (23, 24, 25,
26, 27). In old age a slight and not statistically significant
(13) loss of lipid concentration occurs, especially in the
cerebroside, which is apparently the result of the physio-
logical ageing process; but this opinion is not uncontested
(24).
Similar but more marked quantitative changes are per-
tinent to hepatocerebral degeneration. The proved
significant decrease in neutral lipids (tab. 2) can now be
discussed. The proportion of neutral lipids in the main
fraction of total lipids amounts is only 67% (normal
brains = 84%) in the white matter of cerebrum, about
70% (85%) in the medulla oblongata and 78% (84%) in
the grey matter of cerebrum. The decrease of lipids in the
non-alcoholic hepatogenic degenerated brains is small
and insignificant. The loss of neutral lipids is partly
due to lowered cerebroside especially in the grey matter
of cerebrum where no other lipid loss could be shown.
The decrease of cerebroside in the hepatogen degene-
rated brains of alcoholic type exceeds that associated
with the physiological ageing process and can therefore
be considered pathological.
Apart from this a further factor must be taken into con-
sideration regarding the lower content of neutral lipids
in the total lipids of the pathological brains: correspond-
ing to the definition, the total lipids no longer contain
any proteo groups. According to the methods of FOLCH
et al. (15) the separation of the protein components from
the protein-containing total lipids (fig. 1) results entirely
from the heat coagulation in the extract of normal
brains, but not in the pathological brains: According to
pur studies, the total lipids of these, brains still include
small amounts of proteo groups, probably with a
different composition from those in normal brains. Only
these remaining proteins are bound to the DEAE-
Sephädex column. The loss of eluted neutral lipids
therefore appears too high because the total lipids are
not free of protein and for this reason are found in too
large amounts.
Apart from the cerebroside losses, the white matter of
cerebrum and medulla oblongata show a slight decrease
(p < 0.05) of cholesterol, phosphatidyl choline and
phosphatidyl ethanolamine (tab. 2). Thus there is a
regular decrease of all lipids except sphingomyelin in the
regions of brain rich in white matter. The general
reaction of the brain to disease is the diminution of the
lipids (11), particularly of the "myelin lipids", e. g. in
the descending WALLERIAN degeneration of peripheral
nerves after section (28, 29) in which the content of all
lipids regularly falls. The novum of lipid loss in the
cerebral degeneration with hepatogenic or/and alcoholic
toxic aetiology is the non-uniform diminution of the
neutral sphingolipids.
The brains I and VI which we examined showed only
discret morphological changes such as oedema and
traces of cortical atrophy. The histological characteristics
of hepatocerebral degeneration could only be shown in
two questionable cases. According to our examination,
therefore, there is no exact correlation between morpho-
logy and altered lipid composition in hepatocerebral
degeneration.
However, the decrease of the neutral lipids i. e. cerebro-
side, phosphatidyl choline, phosphatidyl ethanolamine
and cholesterol is striking. We think, therefore, that the
present findings must be classified as a pre-morpho-
logical, biochemically manifest degenerative lesion of
hepatic and/or alcoholic toxic aetiology.
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